Psilocybin
This note is educational and does not provide instructions for nonmedical use. Controlled or intoxicating substances can carry legal, dependence, psychiatric, cardiovascular, and impairment risks, and medical use belongs under qualified supervision.
Summary / What it does
Psilocybin is a classic psychedelic found in certain mushrooms and converted to psilocin in the body. It is being studied clinically for depression, end-of-life distress, and addiction, but unsupervised use carries legal and psychological risks.
Useful cross-links: Neurotransmitter Balance, Glutamate, AMPA, NMDA Modulation, Neurotrophic & Growth Factors. Its effects are best evaluated through the Long Term & Permanent Effects pattern rather than as a single isolated effect.
How it works in the brain (detailed scientific mechanisms)
Psilocin stimulates serotonin 5-HT2A receptors, increasing cortical entropy, glutamate signaling, emotional salience, and network flexibility. Therapeutic models emphasize psychological support, preparation, and integration rather than the molecule alone.
Related mechanism notes: Neurotransmitter Balance, Glutamate, AMPA, NMDA Modulation, Neurotrophic & Growth Factors.
Different variations/forms
Natural mushrooms vary widely in potency and contain multiple compounds. Synthetic psilocybin in clinical trials provides precise dosing and screening. Psilocin is the active metabolite.
Time to action / onset
Onset is usually 20-60 minutes, with peak effects around one to three hours depending on preparation.
Half-life
Psilocin clears in hours, but psychological and behavioral effects can persist through learning and integration.
Dosage
This wiki does not provide nonmedical dosing guidance. Clinical protocols use screening, support, controlled environment, and follow-up.
Positive effects
Potential positives in controlled settings include mood improvement, emotional breakthroughs, reduced rumination, increased openness, and addiction-related insight.
Reported Effects
Anecdotal psilocybin reports often emphasize emotional processing, visual texture, body load, laughter, crying, nature connection, and a feeling that rigid thought patterns loosen. Positive reports can sound therapeutic or spiritually meaningful. Negative reports include nausea, fear, confusion, panic, emotional overwhelm, and difficult material surfacing too quickly.
Side effects / contraindications
Risks include panic, nausea, impaired judgment, accidents, persisting perceptual changes, psychosis or mania in vulnerable individuals, and legal consequences.
Where it is found in food or nature (natural sources)
Psilocybin occurs naturally in multiple Psilocybe and related mushroom species.
Protocol
This wiki does not provide nonmedical dosing guidance. Clinical protocols use psychiatric screening, preparation sessions, supervised administration in a controlled therapeutic environment, and integration follow-up. Personal or family history of psychosis, mania, or schizophrenia-spectrum conditions is a contraindication. Set, setting, and integration are treated as non-negotiable components of the clinical model.
Key Research
- Carhart-Harris et al. (2016): Open-label pilot showed psilocybin produced marked reductions in treatment-resistant depression — pivotal early clinical evidence.
- Davis et al. (2021): Randomized controlled trial demonstrated psilocybin-assisted therapy produced large and durable reductions in MDD versus delayed-start condition.
- Griffiths et al. (2006): Psilocybin produced mystical-type experiences that rated among life’s most personally meaningful events and were associated with sustained positive mood changes at 2 months.
Forms & Sourcing
Research-grade synthetic psilocybin is used in clinical trials under strict protocols. Natural mushrooms vary widely in potency — even within the same species and batch. Decriminalization has occurred in some US cities and states but federal Schedule I status remains. Street products carry identification and contamination risks.
Other notes
Psilocybin should be linked to long-lasting effects only with caution: durable change can be beneficial, neutral, or destabilizing.